A article titled " Metformin intake is associated with better survival in ovarian cancer" was published today in the journal Cancer . Metformin is a drug used to treat type 2 diabetes. The research was done at the Mayo Clinic College of Medicine.
This retrospective study showed that women with epithelial ovarian cancer who were taking Metformin had significantly better survival compared to women with epithelial ovarian cancer who were not taking Metformin. The 5 year disease specific survival for cases vs control was 67% vs 47%.
The conclusion was"The results of this study indicated an association of metformin intake with survival in patients with ovarian cancer. The receipt of metformin was associated with better survival, and the authors concluded that metformin is worthy of clinical trials in ovarian cancer. Cancer 2012. © 2012 American Cancer Society."
This is an interesting line of research and I look forward to seeing the results of future prospective clinical trials. Source : http://onlinelibrary.wiley.com/doi/10.1002/cncr.27706/abstract
Metformin information: http://www.nlm.nih.gov/medlineplus/druginfo/meds/a696005.html
Dee
Every day is a Blessing!
No comments:
Post a Comment